ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
PR Newswire
RADNOR, Pa., Aug. 21, 2026
Did you buy CAPR securities between December 17, 2025 and July 26, 2026?Affected CAPR Investor SummaryWho: Capricor Therapeutics, Inc. (NASDAQ: CAPR)What: Securities fraud class action lawsuit filedClass Period: December 17, 2025 through July 26, 2026Deadline to Seek Lead Plaintiff Status: September 28, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's lead product candidates statistical analysis plan and FDA complianceInvestor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery optionsRADNOR, Pa., Aug. 21, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Capricor Therapeutics, Inc. (Capricor) (NASDAQ: CAPR) on behalf of those who purchased or acquired Capricor securities between December 17, 2025 and July 26, 2026, inclusive. The lawsuit is filed in the United States District Court for the Southern District of California and is captioned Darren Ngasseu Nkamga v. Capricor Therapeutics, Inc., No. 26-cv-04385 (S.D. Cal.). Investors have until September 28, 2026, to file for lead plaintiff status.
